Literature DB >> 11349719

Cold ischemia time: an independent predictor of increased HLA class I antibody production after rejection of a primary cadaveric renal allograft.

C F Bryan1, A M Luger, J Martinez, N Muruve, P W Nelson, G E Pierce, G Ross, C F Shield, B A Warady, M I Aeder, T S Helling.   

Abstract

BACKGROUND: Cadaveric kidneys experiencing longer cold ischemia time (CIT) are associated with higher levels of delayed graft function, acute rejection, and early graft loss. One mechanism to explain these results is that ischemia/reperfusion (I/R) injury makes the allograft more immunogenic by upregulating molecules involved in the immune response (e.g., HLA Class I/II).
METHODS: We evaluated the influence of CIT on the production of HLA Class I antibody level, measured by an antihuman globulin panel reactive antibody (AHG PRA) level, in 90 unsensitized recipients of primary cadaveric renal transplants (from a total of 1442 between 1985 and 1997) who rejected their kidneys.
RESULTS: By multivariate analysis, a CIT of 15 hr or more (vs. < 15 hr) independently increased the risk of the AHG Class I PRA level being > or = 20% after unsensitized patients rejected their first kidneys (relative risk=3.57; 95% confidence interval=1.26 to 10.14; P=0.01), despite the same degree of Class I/II mismatch between the two CIT groups. The overall mean peak PRA level after primary kidney rejection was significantly lower for the CIT < 15 hr group (25.9%+/-33.9; n=24) compared with the CIT > or = 15 hr group (46.3%+/-36.5; n=66) (P<0.001).
CONCLUSION: Longer CIT induces a humorally more immunogenic kidney.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11349719     DOI: 10.1097/00007890-200104150-00009

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Pure versus hand-assisted retroperitoneoscopic live donor nephrectomy: a retrospective cohort study of 1508 transplants from two centers.

Authors:  Hiroshi Noguchi; Yoichi Kakuta; Masayoshi Okumi; Kazuya Omoto; Yasuhiro Okabe; Hideki Ishida; Masafumi Nakamura; Kazunari Tanabe
Journal:  Surg Endosc       Date:  2019-03-19       Impact factor: 4.584

2.  Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Authors:  Chao Hu; Long Li; Peipei Ding; Ling Li; Xiaowen Ge; Long Zheng; Xuanchuan Wang; Jina Wang; Weitao Zhang; Na Wang; Hongyu Gu; Fan Zhong; Ming Xu; Ruiming Rong; Tongyu Zhu; Weiguo Hu
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

3.  Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants.

Authors:  Eric K Chow; Sandra DiBrito; Xun Luo; Corey E Wickliffe; Allan B Massie; Jayme E Locke; Sommer E Gentry; Jacqueline Garonzik-Wang; Dorry L Segev
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

4.  Living-donor kidney transplantation: the Freiburg experience.

Authors:  Oliver Drognitz; Johannes Donauer; Judith Kamgang; Peter Baier; Hannes Neeff; Christian Lohrmann; Martin Pohl; Ulrich Theodor Hopt; Günter Kirste; Przemyslaw Pisarski
Journal:  Langenbecks Arch Surg       Date:  2006-08-19       Impact factor: 3.445

5.  Optimized outcomes for renal allografts with cold ischemic times of 20 h or greater.

Authors:  Anja Gallinat; Andreas Paul; Thomas Minor; Jürgen W Treckmann; Ernesto P Molmenti; Oliver Witzke; Georgios C Sotiropoulos
Journal:  Int Urol Nephrol       Date:  2012-07-01       Impact factor: 2.370

6.  Distinct Phenotypes of Kidney Transplant Recipients in the United States with Limited Functional Status as Identified through Machine Learning Consensus Clustering.

Authors:  Charat Thongprayoon; Caroline C Jadlowiec; Wisit Kaewput; Pradeep Vaitla; Shennen A Mao; Michael A Mao; Napat Leeaphorn; Fawad Qureshi; Pattharawin Pattharanitima; Fahad Qureshi; Prakrati C Acharya; Pitchaphon Nissaisorakarn; Matthew Cooper; Wisit Cheungpasitporn
Journal:  J Pers Med       Date:  2022-05-25

Review 7.  Renal transplantation in high-risk patients.

Authors:  Nicole A Weimert; Rita R Alloway
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 8.  Chemokine-directed strategies to attenuate allograft rejection.

Authors:  Austin D Schenk; Joshua M Rosenblum; Robert L Fairchild
Journal:  Clin Lab Med       Date:  2008-09       Impact factor: 1.935

9.  Association of Cold Ischemia Time With Acute Renal Transplant Rejection.

Authors:  Merve Postalcioglu; Arnaud D Kaze; Benjamin C Byun; Andrew Siedlecki; Stefan G Tullius; Edgar L Milford; Julie M Paik; Reza Abdi
Journal:  Transplantation       Date:  2018-07       Impact factor: 4.939

10.  Short-time intermittent preexposure of living human donors to hyperoxia improves renal function in early posttransplant period: a double-blind randomized clinical trial.

Authors:  Kamran Montazeri; Mohammadali Vakily; Azim Honarmand; Parviz Kashefi; Mohammadreza Safavi; Shahram Taheri; Bahram Rasoulian
Journal:  J Transplant       Date:  2011-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.